Skip to content
Oncology Research Hub

California

Cancer clinical trials in California

984 cancer studies are recruiting participants at sites in 150 cities across California as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse California by city

Cities with the most studies recruiting right now.

Every California city with a recruiting study

By research area: Breast Cancer (253), Lung Cancer (245), Lymphoma (221), Prostate Cancer (157), Pancreatic Cancer (66), Melanoma (42).

Los Angeles (384), Duarte (250), San Francisco (214), Sacramento (119), Irvine (117), Orange (117), La Jolla (116), Palo Alto (100), San Diego (93), Santa Monica (67), Santa Rosa (58), Beverly Hills (52), Stanford (51), Newport Beach (50), Long Beach (44), Walnut Creek (41), Oakland (40), Vallejo (38), Torrance (37), Roseville (36), Fullerton (32), Loma Linda (32), Anaheim (30), Fremont (30), Modesto (30), Fresno (27), San Jose (27), Santa Barbara (25), Santa Clara (25), Stockton (25), Burbank (24), Fountain Valley (22), San Rafael (22), Dublin (21), San Leandro (21), Berkeley (20), Glendale (20), South San Francisco (20), Los Alamitos (19), Arroyo Grande (18), Riverside (18), San Luis Obispo (18), Carmichael (17), Elk Grove (17), Pasadena (17), Rocklin (17), South Pasadena (17), Upland (17), Woodland (17), San Mateo (16), Sunnyvale (16), Lancaster (15), Bellflower (14), Santa Maria (14), Fontana (13), Ontario (13), Panorama City (13), San Marcos (13), Auburn (12), Clovis (12), Santa Cruz (12), Tarzana (12), Vacaville (12), Antioch (11), Bakersfield (11), Baldwin Park (11), Napa (11), Redwood City (11), Richmond (11), Woodland Hills (11), Cameron Park (10), Harbor City (10), Laguna Hills (10), Marysville (10), Mountain View (10), Rancho Mirage (10), Truckee (10), Whittier (10), Chico (9), Encinitas (9), Huntington Beach (9), Madera (9), Burlingame (8), Downey (8), Emeryville (8), Davis (7), Merced (7), Cerritos (6), Costa Mesa (6), Martinez (6), Oxnard (6), Rohnert Park (6), Yorba Linda (6), Corona (5), Palm Springs (5), Rancho Cordova (5), Salinas (5), St. Helena (5), Alhambra (4), Castro Valley (4), Greenbrae (4), Marina del Rey (4), Novato (4), Oceanside (4), Redlands (4), Van Nuys (4), Ventura (4), West Los Angeles (4), Monterey (3), Santa Clarita (3), Vista (3), Arcadia (2), Atascadero (2), Buena Park (2), Concord (2), Encino (2), Mather (2), Murrieta (2), Newport (2), Pleasanton (2), and 30 more.

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in California

Basic details from each study's public record (the 12 most recently updated of 984). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

    • Phase 2
    • Ages 18 and older
    • Female participants
    Sponsor
    Stephen Shiao
    Recruiting in
    Los Angeles
    Registry record
    NCT05491226 · updated
  2. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Cerritos · Los Angeles · Orange · and 1 more U.S. location
    Registry record
    NCT06324357 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in California on ClinicalTrials.gov.

Lung cancer: recently updated in California

  1. Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Teligene US
    Recruiting in
    Glendale
    Registry record
    NCT05168566 · updated
  2. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NovoCure GmbH
    Recruiting in
    Fullerton · Newport Beach
    Registry record
    NCT06216301 · updated
  3. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Duarte · Irvine · La Jolla · and 1 more U.S. location
    Registry record
    NCT06287775 · updated
  4. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Santa Rosa
    Registry record
    NCT06983743 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in California on ClinicalTrials.gov.

Prostate cancer: recently updated in California

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    West Los Angeles
    Registry record
    NCT04038502 · updated
  2. Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

    • No phase
    • All ages
    • Male participants
    Sponsor
    University of California, San Diego
    Recruiting in
    La Jolla
    Registry record
    NCT05882253 · updated
  3. Folate Study in Men With Advanced Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    University of California, San Diego
    Recruiting in
    La Jolla
    Registry record
    NCT06536374 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in California on ClinicalTrials.gov.

Lymphoma: recently updated in California

  1. A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

    • No phase
    • Ages 1 to 25
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Los Angeles
    Registry record
    NCT05621291 · updated
  2. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Burbank · Duarte · Irvine · and 3 more U.S. locations
    Registry record
    NCT06724237 · updated
  3. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Clovis · Fullerton · Los Angeles · and 3 more U.S. locations
    Registry record
    NCT06806033 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in California on ClinicalTrials.gov.

Ask about studies in California

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call